Normocalcemic Hyperparathyroidism with Elevated PTH
Your laboratory findings—ionized calcium 1.26 mmol/L (normal) with PTH 111.3 pg/mL (elevated)—most likely represent normocalcemic primary hyperparathyroidism (NPHPT), but you must systematically exclude secondary causes before confirming this diagnosis.
Immediate Diagnostic Workup Required
1. Exclude Secondary Hyperparathyroidism (Most Common Cause)
Measure 25-hydroxyvitamin D immediately. Vitamin D deficiency is the leading cause of elevated PTH with normal calcium and must be ruled out first 1. If 25-hydroxyvitamin D is <30 ng/mL (<50 nmol/L), you have secondary hyperparathyroidism from vitamin D deficiency, not primary disease 1, 2.
Assess dietary calcium intake. Confirm the patient consumes 1,000–1,200 mg elemental calcium daily 1. Low calcium intake mimics secondary hyperparathyroidism by stimulating PTH secretion 1.
Check renal function with serum creatinine and eGFR. PTH rises when eGFR falls below 60 mL/min/1.73 m², making chronic kidney disease a key differential 3, 1. An eGFR ≥60 mL/min/1.73 m² is required to exclude CKD-related secondary hyperparathyroidism 3.
2. Confirm Calcium Status with Corrected Total Calcium
Obtain serum albumin and calculate corrected total calcium using the formula: Corrected Ca (mg/dL) = Total Ca + 0.8 × [4 – albumin (g/dL)] 4, 1. Your ionized calcium of 1.26 mmol/L (≈5.04 mg/dL) falls within the normal range of 1.15–1.36 mmol/L 1, but corrected total calcium provides additional diagnostic clarity 4.
3. Measure Serum Phosphorus
Low-normal or low phosphorus supports primary hyperparathyroidism, as PTH increases renal phosphate excretion 3. Normal or elevated phosphorus suggests secondary hyperparathyroidism from CKD or vitamin D deficiency 1.
Diagnostic Interpretation Algorithm
If 25-OH Vitamin D <30 ng/mL:
- Diagnosis: Secondary hyperparathyroidism from vitamin D deficiency 1, 2
- Action: Start ergocalciferol 50,000 IU monthly for 6 months 2, then recheck PTH after repletion 1
- Do not diagnose NPHPT until vitamin D is repleted and PTH remains elevated 3
If 25-OH Vitamin D ≥30 ng/mL AND eGFR ≥60 mL/min/1.73 m² AND adequate calcium intake:
- Diagnosis: Normocalcemic primary hyperparathyroidism (NPHPT) 3
- Action: Proceed to additional PHPT workup (see below) 3
If eGFR <60 mL/min/1.73 m²:
- Diagnosis: Secondary hyperparathyroidism from CKD 1, 3
- Action: Manage per CKD-mineral bone disorder guidelines 1
Additional Workup for Confirmed NPHPT
Once secondary causes are excluded, complete the following:
Measure 24-hour urinary calcium or spot urine calcium/creatinine ratio. Severe hypercalciuria (>300 mg/24 hr) is a surgical indication even with normal serum calcium 3, 2.
Obtain renal ultrasound to assess for nephrocalcinosis or kidney stones 2.
Order bone density scan (DEXA) to evaluate for osteoporosis (T-score ≤-2.5), which is a surgical indication 3, 2.
Consider parathyroid imaging (ultrasound and/or 99mTc-sestamibi SPECT/CT) only if surgery is planned—imaging is for surgical planning, not diagnosis 2, 3.
Management Decision Points
Surgical Referral Indications (Even with Normal Calcium)
Refer to endocrinology and an experienced parathyroid surgeon if any of the following are present 3, 2:
- Age <50 years 3
- eGFR <60 mL/min/1.73 m² 3, 2
- Osteoporosis (T-score ≤-2.5 at any site) 3
- 24-hour urinary calcium >300 mg 3
- Nephrolithiasis or nephrocalcinosis 3
- Disabling neurocognitive symptoms (depression, memory loss, "brain fog") 3
- Patient preference for definitive treatment 3
NPHPT is not benign—it carries the same risk profile as hypercalcemic PHPT, including bone loss and kidney stones 3.
Medical Management for Non-Surgical Candidates
If surgery is declined or contraindicated:
- Maintain 25-OH vitamin D >20 ng/mL with cholecalciferol or ergocalciferol supplementation 3, 2
- Ensure normal calcium intake of 1,000–1,200 mg/day; avoid both high and low calcium diets 3
- Monitor serum calcium, phosphorus, and PTH every 3 months 2, 1
- Repeat bone density scan every 1–2 years 2
- Avoid calcitriol or active vitamin D analogs, as they increase intestinal calcium absorption and can precipitate hypercalcemia 3
Critical PTH Measurement Considerations
PTH assays vary by up to 47% between different generations—always use assay-specific reference ranges 3, 1. Your PTH of 111.3 pg/mL may be interpreted differently depending on the assay used 3.
PTH should be measured in EDTA plasma (not serum) and kept at 4°C for optimal stability 3, 1.
Biotin supplementation interferes with PTH immunoassays—patients must discontinue biotin ≥72 hours before testing 3.
Biological variation of PTH is ~20% in healthy individuals—a change >54% is required to be clinically meaningful 3.
PTH concentrations are influenced by age, race, and BMI:
- PTH rises with age, especially after 60 years, due to declining GFR 3
- Black individuals have higher baseline PTH than White individuals 3
- Higher BMI correlates with higher PTH 3
Common Pitfalls to Avoid
Do not diagnose NPHPT without first excluding vitamin D deficiency and low calcium intake—these reversible factors are the most common causes of normocalcemic PTH elevation 3, 1.
Do not order parathyroid imaging before confirming the biochemical diagnosis—imaging is for surgical planning, not diagnosis 2.
Do not assume normal ionized calcium rules out PHPT—13 of 25 patients with histologically confirmed PHPT had normal corrected calcium but elevated ionized calcium 5.
Do not use total calcium alone when albumin is abnormal—correction formulas have limitations, and ionized calcium is the gold standard 4, 5.
Recognize that "normal" PTH in the setting of hypercalcemia is inappropriate—PTH should be suppressed (<20 pg/mL) when calcium is elevated 6, 3.